Mifepristone decreases nicotine intake in dependent and non-dependent adult rats

Addiction to tobacco and nicotine products has adverse health effects and afflicts more than a billion people worldwide. Therefore, there is an urgent need for new treatments to reduce tobacco and nicotine use. Glucocorticoid receptor blockade shows promise as a novel treatment for drug abuse and stress-related disorders. The aim of these studies was to investigate if glucocorticoid receptor blockade with mifepristone diminishes the reinforcing properties of nicotine in rats with intermittent or daily long access to nicotine. The rats self-administered 0.06 mg/kg/inf of nicotine for 6 h per day, with either intermittent (3 days per week) or daily access (7 days per week) for 4 weeks before treatment with mifepristone. Daily nicotine self-administration models regular smoking, while intermittent nicotine self-administration models occasional smoking. To determine if the rats were dependent, they were treated with the nicotinic acetylcholine receptor antagonist mecamylamine, and somatic signs were recorded. The rats with intermittent access to nicotine had a higher level of nicotine intake per session than those with daily access, but only the rats with daily access to nicotine showed signs of dependence. Furthermore, mecamylamine increased nicotine intake during the first hour of access in rats with daily access but not in those with intermittent access. Mifepristone decreased total nicotine intake in rats with intermittent and daily access to nicotine. Moreover, mifepristone decreased the total distance traveled and rearing in the open field test and operant responding for food pellets. These findings indicate that mifepristone decreases the reinforcing effects of nicotine and food, but it might also be somewhat sedative.

[1]  L. Knackstedt,et al.  Regulation of cocaine-related behaviours by estrogen and progesterone , 2022, Neuroscience & Biobehavioral Reviews.

[2]  Adriaan W. Bruijnzeel,et al.  Dopamine D1-like receptor blockade and stimulation decreases operant responding for nicotine and food in male and female rats , 2022, Scientific Reports.

[3]  P. Kenny,et al.  Neurobiological Mechanisms of Nicotine Reward and Aversion , 2022, Pharmacological Reviews.

[4]  M. Febo,et al.  Oxycodone decreases anxiety-like behavior in the elevated plus-maze test in male and female rats , 2021, bioRxiv.

[5]  T. Napier,et al.  Mitochondrial function influences expression of methamphetamine-induced behavioral sensitization , 2021, Scientific Reports.

[6]  Thuy Tran,et al.  Stress Promoted Nicotine Intake in a Rat Model of Tobacco Smoking , 2021, Addiction Research.

[7]  M. Febo,et al.  Adolescent nicotine treatment causes robust locomotor sensitization during adolescence but impedes the spontaneous acquisition of nicotine intake in adult female Wistar rats , 2021, Pharmacology Biochemistry and Behavior.

[8]  Adriaan W. Bruijnzeel,et al.  Rewarding effects of nicotine self-administration increase over time in male and female rats. , 2021, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[9]  R. Ciccocioppo,et al.  Effect of Glucocorticoid Receptor Antagonism on Alcohol Self-Administration in Genetically-Selected Marchigian Sardinian Alcohol-Preferring and Non-Preferring Wistar Rats , 2021, International journal of molecular sciences.

[10]  E. Zorrilla,et al.  Glucocorticoid Receptor Antagonist Mifepristone Does Not Alter Innate Anxiety-Like Behavior in Genetically-Selected Marchigian Sardinian (msP) Rats , 2021, International journal of molecular sciences.

[11]  G. Koob.  Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development , 2020, Pharmacological Reviews.

[12]  J. Crabbe,et al.  Targeting the glucocorticoid receptor reduces binge-like drinking in High Drinking in the Dark (HDID-1) mice. , 2020, Alcoholism, clinical and experimental research.

[13]  Varenicline , 2019, Reactions Weekly.

[14]  M. Sofuoglu,et al.  Role of Exogenous Progesterone in the Treatment of Men and Women with Substance Use Disorders: A Narrative Review , 2018, CNS Drugs.

[15]  M. Febo,et al.  Overexpression of CRF in the BNST diminishes dysphoria but not anxiety-like behavior in nicotine withdrawing rats , 2016, European Neuropsychopharmacology.

[16]  M. Carroll,et al.  Sex differences in attenuation of nicotine reinstatement after individual and combined treatments of progesterone and varenicline , 2016, Behavioural Brain Research.

[17]  G. Koob,et al.  Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals. , 2015, The Journal of clinical investigation.

[18]  R. Tyndale,et al.  Effect of food training and training dose on nicotine self-administration in rats , 2014, Behavioural Brain Research.

[19]  R. Veen,et al.  Mifepristone treatment affects the response to repeated amphetamine injections, but does not attenuate the expression of sensitization , 2013, Psychopharmacology.

[20]  G. Koob,et al.  Corticosteroid-Dependent Plasticity Mediates Compulsive Alcohol Drinking in Rats , 2012, The Journal of Neuroscience.

[21]  G. Koob,et al.  Robust Escalation of Nicotine Intake with Extended Access to Nicotine Self-Administration and Intermittent Periods of Abstinence , 2012, Neuropsychopharmacology.

[22]  A. Bruijnzeel.  Tobacco addiction and the dysregulation of brain stress systems , 2012, Neuroscience & Biobehavioral Reviews.

[23]  S. Bartlett,et al.  Mifepristone in the Central Nucleus of the Amygdala Reduces Yohimbine Stress-Induced Reinstatement of Ethanol-Seeking , 2012, Neuropsychopharmacology.

[24]  A. Young,et al.  Glucocorticoid receptors in the prefrontal cortex regulate stress-evoked dopamine efflux and aspects of executive function , 2011, Proceedings of the National Academy of Sciences.

[25]  Kenneth W Lin,et al.  Nicotine receptor partial agonists for smoking cessation. , 2011, American family physician.

[26]  S. Shiffman,et al.  Smoking cessation behavior among intermittent smokers versus daily smokers. , 2011, American journal of public health.

[27]  M. Bardo,et al.  Environmental-induced differences in corticosterone and glucocorticoid receptor blockade of amphetamine self-administration in rats , 2011, Psychopharmacology.

[28]  Rajita Sinha,et al.  Stress decreases the ability to resist smoking and potentiates smoking intensity and reward , 2011, Journal of psychopharmacology.

[29]  C. Blasey,et al.  Mifepristone Reduces Weight Gain and Improves Metabolic Abnormalities Associated With Risperidone Treatment in Normal Men , 2010, Obesity.

[30]  V. Quiñones-Jenab,et al.  Progesterone attenuates cocaine-induced responses , 2010, Hormones and Behavior.

[31]  C. Hodge,et al.  CRF-1 Antagonist and CRF-2 Agonist Decrease Binge-Like Ethanol Drinking in C57BL/6J Mice Independent of the HPA Axis , 2010, Neuropsychopharmacology.

[32]  Thaddeus S Block,et al.  Mifepristone treatment of olanzapine-induced weight gain in healthy men , 2009, Advances in therapy.

[33]  E. Mitchell,et al.  Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers , 2009, Human psychopharmacology.

[34]  R. See,et al.  Attenuation of cocaine-seeking by progesterone treatment in female rats , 2009, Psychoneuroendocrinology.

[35]  V. Regitz-Zagrosek,et al.  Sex Steroid Hormones , 2009 .

[36]  K. Rice,et al.  Restraint stress and ethanol consumption in two mouse strains. , 2008, Alcoholism, clinical and experimental research.

[37]  A. Bruijnzeel,et al.  Effects of the CRF receptor antagonist d-Phe CRF(12–41) and the α2-adrenergic receptor agonist clonidine on stress-induced reinstatement of nicotine-seeking behavior in rats , 2007, Neuropharmacology.

[38]  R. Sinha,et al.  Sex steroid hormones, stress response, and drug craving in cocaine-dependent women: implications for relapse susceptibility. , 2007, Experimental and clinical psychopharmacology.

[39]  M. Gold,et al.  Antagonism of CRF Receptors Prevents the Deficit in Brain Reward Function Associated with Precipitated Nicotine Withdrawal in Rats , 2007, Neuropsychopharmacology.

[40]  G. Koob,et al.  Extended Access to Nicotine Self-Administration Leads to Dependence: Circadian Measures, Withdrawal Measures, and Extinction Behavior in Rats , 2007, Journal of Pharmacology and Experimental Therapeutics.

[41]  S. Evans,et al.  Exogenous Progesterone Attenuates the Subjective Effects of Smoked Cocaine in Women, but not in Men , 2006, Neuropsychopharmacology.

[42]  V. Denoble,et al.  Intravenous nicotine self-administration in rats: effects of mecamylamine, hexamethonium and naloxone , 2006, Psychopharmacology.

[43]  G. Chiara,et al.  Preferential increase of extracellular dopamine in the rat nucleus accumbens shell as compared to that in the core during acquisition and maintenance of intravenous nicotine self-administration , 2006, Psychopharmacology.

[44]  J. Difranza,et al.  A sensitization-homeostasis model of nicotine craving, withdrawal, and tolerance: integrating the clinical and basic science literature. , 2005, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[45]  N. Chaudhri,et al.  Sex differences in the contribution of nicotine and nonpharmacological stimuli to nicotine self-administration in rats , 2005, Psychopharmacology.

[46]  Andrew J Waters,et al.  Cue-provoked craving and nicotine replacement therapy in smoking cessation. , 2004, Journal of consulting and clinical psychology.

[47]  K Straif,et al.  Tobacco smoking and cancer: a brief review of recent epidemiological evidence. , 2004, Lung cancer.

[48]  J. Ambrose,et al.  The pathophysiology of cigarette smoking and cardiovascular disease: an update. , 2004, Journal of the American College of Cardiology.

[49]  Athina Markou,et al.  Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats , 2004, Psychopharmacology.

[50]  S. Russo,et al.  Gonadal hormones differentially modulate cocaine-induced conditioned place preference in male and female rats , 2003, Neuroscience.

[51]  I Campbell,et al.  Nicotine replacement therapy in smoking cessation. , 2003, Thorax.

[52]  M. Le Moal,et al.  The Glucocorticoid Receptor as a Potential Target to Reduce Cocaine Abuse , 2003, The Journal of Neuroscience.

[53]  L. Barré,et al.  Short-term pharmacokinetics and brain distribution of mecamylamine as a preliminary to carbon-11 labeling for nicotinic receptor investigation. , 2003, Journal of pharmaceutical sciences.

[54]  J. Rose,et al.  Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking , 2001, Pharmacology, Biochemistry and Behavior.

[55]  J. McEvoy,et al.  Mecamylamine increases cigarette smoking in psychiatric patients. , 2000, Journal of clinical psychopharmacology.

[56]  A. Phillips,et al.  Chronic corticosterone enhances the rewarding effect of hypothalamic self-stimulation in rats 1 1 Published on the World Wide Web on 30 July 2000. , 2000, Brain Research.

[57]  M. Damaj,et al.  Pharmacological Characterization of Nicotine-Induced Seizures in Mice 1 , 1999 .

[58]  S. H. Ahmed,et al.  Long-lasting increase in the set point for cocaine self-administration after escalation in rats , 1999, Psychopharmacology.

[59]  G. Koob,et al.  Blockade of Nicotine Self-Administration with Nicotinic Antagonists in Rats , 1999, Pharmacology Biochemistry and Behavior.

[60]  I. Stolerman,et al.  Plasma nicotine and cotinine levels following intravenous nicotine self-administration in rats , 1999, Psychopharmacology.

[61]  T. Svensson,et al.  Nicotine and food induced dopamine release in the nucleus accumbens of the rat: Putative role of α7 nicotinic receptors in the ventral tegmental area , 1998, Neuroscience.

[62]  M. Barrot,et al.  Dopamine-dependent responses to morphine depend on glucocorticoid receptors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[63]  M. Barrot,et al.  Glucocorticoids and behavioral effects of psychostimulants. I: locomotor response to cocaine depends on basal levels of glucocorticoids. , 1997, The Journal of pharmacology and experimental therapeutics.

[64]  C. Fahlke,et al.  Facilitation of ethanol consumption by intracerebroventricular infusions of corticosterone , 1996, Psychopharmacology.

[65]  J. Salamone,et al.  Nucleus accumbens dopamine release increases during instrumental lever pressing for food but not free food consumption , 1994, Pharmacology Biochemistry and Behavior.

[66]  M. Le Moal,et al.  Corticosterone in the range of stress-induced levels possesses reinforcing properties: implications for sensation-seeking behaviors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[67]  P. Piazza,et al.  Rats orally self-administer corticosterone , 1993, Brain Research.

[68]  N. Benowitz,et al.  Intravenous nicotine replacement suppresses nicotine intake from cigarette smoking. , 1990, The Journal of pharmacology and experimental therapeutics.

[69]  P. Jones,et al.  Evidence of prednisolone induced mood change ('steroid euphoria') in patients with chronic obstructive airways disease. , 1988, British journal of clinical pharmacology.

[70]  D. Philibert,et al.  RU 38486: a potent antiglucocorticoid in vitro and in vivo. , 1985, Journal of steroid biochemistry.

[71]  X. Bertagna,et al.  The new steroid analog RU 486 inhibits glucocorticoid action in man. , 1984, The Journal of clinical endocrinology and metabolism.

[72]  R. Miller,et al.  Effect of dose on the pharmacokinetics of intravenous nicotine in the rat. , 1977, Drug metabolism and disposition: the biological fate of chemicals.

[73]  V. Quiñones-Jenab,et al.  Effects of RU 486 and tamoxifen on cocaine-induced behavioral and endocrinologic activations in male and female Fischer rats. , 2008, Ethnicity & disease.

[74]  T. Robinson,et al.  Sex Differences and Hormonal Influences on Acquisition of Cocaine Self-Administration in Rats , 2006, Neuropsychopharmacology.

[75]  C. Fahlke,et al.  Consequence of long-term exposure to corticosterone or dexamethasone on ethanol consumption in the adrenalectomized rat, and the effect of type I and type II corticosteroid receptor antagonists , 2005, Psychopharmacology.

[76]  W. Corrigall,et al.  Nicotine maintains robust self-administration in rats on a limited-access schedule , 2004, Psychopharmacology.

[77]  M. Jarvik,et al.  Influencing cigarette smoking with nicotine antagonists , 2004, Psychopharmacologia.

[78]  Josue P. Keely,et al.  Shape of the relapse curve and long-term abstinence among untreated smokers. , 2004, Addiction.

[79]  R. Griffiths,et al.  Effects of mecamylamine on human cigarette smoking and subjective ratings , 2004, Psychopharmacology.

[80]  K. Perkins.  Nicotine self-administration. , 1999, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[81]  E. Levin,et al.  Combined effects of nicotine and mecamylamine in attenuating smoking satisfaction. , 1994 .